Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

The hyponatremic patient: practical focus on therapy

S M Lauriat¹, T Berl

¹Department of Medicine, University of Colorado School of Medicine, Denver 80262, USA.

Journal of the American Society of Nephrology : JASN

|October 23, 1997

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2010

Same author

p38 MAP kinase modulates liver cell volume through inhibition of membrane Na+ permeability.

The Journal of clinical investigation·2001

Same author

The expression of the gamma subunit of Na-K-ATPase is regulated by osmolality via C-terminal Jun kinase and phosphatidylinositol 3-kinase-dependent mechanisms.

Proceedings of the National Academy of Sciences of the United States of America·2001

Same author

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

The New England journal of medicine·2001

Same author

Long-term adaptation of renal cells to hypertonicity: role of MAP kinases and Na-K-ATPase.

American journal of physiology. Renal physiology·2001

Same author

Preclinical pharmacologic basis for clinical use of rhIL-11 as an effective platelet-support agent.

Oncology (Williston Park, N.Y.)·2000